Effects of intravenously administered C-type natriuretic peptide in humans: Comparison with atrial natriuretic peptide

Hypertension Research

Volumn 21, Issue 1, 1998, Pages 7-13

  Igaki, Toshio ^a   Itoh, Hiroshi ^a   Suga, Shin Ichi ^a   Hama, Norio ^a   Ogawa, Yoshihiro ^a   Komatsu, Yasato ^a   Yamashita, Jun ^a   Doi, Kentaro ^a   Chun, TaeHwa ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Atrial natriuretic peptide (ANP); Blood pressure; C type natriuretic peptide (CNP); Guanosine 3 ,5 cyclic monophosphate (cGMP); Natriuresis

Indexed keywords

ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; NATRIURETIC PEPTIDE TYPE C;

ADULT; ALDOSTERONE RELEASE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIURETIC ACTIVITY; HEART RATE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM;

EID: 0031957394     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.21.7     Document Type: Review

References (31)

1. de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H: A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Science 1981; 28: 89-94.
2. Kangawa K, Matsuo H: Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide. Biochem Biophys Res Commun 1984; 118: 131-139.
3. Sudoh T, Kangawa K, Minamino N, Matsuo H: A new natriuretic peptide in porcine brain. Nature 1988; 332: 78-80.
4. Nakao K, Ogawa Y, Suga S, Imura H: Molecular biology and biochemistry of the natriuretic peptide system I: natriuretic peptides. J Hypertens 1992; 10: 907-912.
5. Sudoh T, Minamino N, Kangawa K, Matsuo H: C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 1990; 168: 863-870.
6. Komatsu Y, Nakao K, Suga S, et al: C-type natriuretic peptide (CNP) in rats and humans. Endocrinology 1991; 129: 1104-1106.
7. Ogawa Y, Nakao K, Nakagawa O, et al: Human C-type natriuretic peptide: characterization of the gene and peptide. Hypertension 1992; 19: 809-813.
8. Kaneko T, Shirakami G, Nakao K, et al: C-type natriuretic peptide (CNP) is the major natriuretic peptide in human cerebrospinal fluid. Brain Res 1993; 612: 104-109.
9. Shirakami G, Itoh H, Suga S, et al: Central action of C-type natriuretic peptide on vasopressin secretion in conscious rats. Neurosci Lett 1993; 159: 25-28.
10. Komatsu Y, Nakao K, Itoh H, Suga S, Ogawa Y, Imura H: Vascular natriuretic peptide. Lancet 1992; 340: 622.
11. Suga S, Nakao K, Itoh H, et al: Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-β: possible existence of "vascular natriuretic peptide system". J Clin Invest 1992; 90: 1145-1149.
12. Komatsu Y, Itoh H, Suga S, et al: Regulation of endothelial production of C-type natriuretic peptide in coculture with vascular smooth muscle cells: role of the vascular natriuretic peptide system in vascular growth inhibition. Circ Res 1996; 78: 606-614.
13. Igaki T, Itoh H, Suga S, et al: Insulin suppresses endothelial secretion of C-type natriuretic peptide, a novel endothelium-derived relaxing peptide. Diabetes 1996; 45 (Suppl 3): S62-S64.
14. Doi K, Itoh H, Komatsu Y, et al: Vascular endothelial growth factor suppresses C-type natriuretic peptide secretion. Hypertension 1996; 27 (part 2): 811-815.
15. Suga S, Nakao K, Hosoda K, et al: Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide and C-type natriuretic peptide. Endocrinology 1992; 130: 229-239.
16. Hama N, Itoh H, Shirakami G, et al: Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients. Biochem Biophys Res Commun 1994; 198: 1177-1182.
17. Furuya M, Yoshida M, Hayashi Y, et al: C-type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells. Biochem Biophys Res Commun 1991; 177: 927-931.
18. Porter J, Catalano R, McEnroe G, Lewicki J, Protter A: C-type natriuretic peptide inhibits growth factor-dependent DNA synthesis in smooth muscle cells. Am J Physiol 1992: 263: C1001-C1006.
19. Itoh H, Pratt RE, Dzau VJ: Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest 1990; 86: 1690-1697.
20. Itoh H, Nakao K: Antagonism between vascular renin-angiotensin and natriuretic peptide systems in vascular remodeling. Blood Press 1994; 3 (Suppl 5): 49-53.
21. Nakao K, Itoh H, Yoshimasa T, Imura H: C-type natriuretic peptide (CNP) as a novel endothelium-derived relaxing peptide: occurrence of vascular natriuretic peptide system. in Masaki T (ed): Endothelium-derived factors and vascular functions, Amsterdam, Elsevier Science Publishers B.V., 1994, pp 123-129.
22. Sugawara A, Nakao K, Morii N, et al: Significance of α-human atrial natriuretic polypeptide as a hormone in man. Hypertension 1986; 8 (Suppl I): 1151-1155.
23. Homma M, Satoh T, Takezawa J, Ui M: An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue. Biochem Med 1977; 18: 257-273.
24. Itoh H, Nakao K, Mukoyama M, et al: Effects of intravenously administered β-human atrial natriuretic polypeptide in humans. Hypertension 1988; 11: 697-702.
25. Saito Y, Nakao K, Nishimura K, et al: Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation 1987; 76: 115-124.
26. Yoshimura M, Yasue H, Morita E, et al: Hemodynamic, renal and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 1991; 84: 1581-1588.
27. Kenny AJ, Stephenson A: Role of endopeptidase-24.11 in the inactivation of atrial natriuretic peptide. FEBS Lett 1988; 232: 1-8.
28. Komatsu Y, Itoh H, Suga S, et al: Regulation of secretion and clearance of C-type natriuretic peptide in the interaction of vascular endothelial cells and smooth muscle cells. J Hypertens 1996; 14: 585-592.
29. Hunt PJ, Richards A, Espiner E, Nicholls M, Yandle T: Bioactivity and metabolism of C-type natriuretic peptide in normal man. J Clin Endocrinol Metab 1994; 78: 1428-1435.
30. Cargill R, Struthers A, Lipworth B: Human C-type natriuretic peptide: effects on the haemodynamic and endocrine responses to angiotensin II. Cardiovasc Res 1995; 29: 108-111.
31. Mattingly MT, Brandt RR, Heublein DM, et al: Pres-ence of C-type natriuretic peptide in human kidney and urine. Kidney Int 1994; 46: 744-747.